-
B125576-1mgCdk inhibitor: potently inhibits cdk1 and cdk2.
-
B125576-25mgCdk inhibitor: potently inhibits cdk1 and cdk2.
-
B125576-50mgCdk inhibitor: potently inhibits cdk1 and cdk2.
-
B125576-5mgCdk inhibitor: potently inhibits cdk1 and cdk2.
-
E192613-100mgProduct description:BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <:2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with
-
E192613-250mgProduct description:BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <:2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with
-
E192613-25mgProduct description:BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <:2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with
-
E192613-50mgProduct description:BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <:2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with
-
E192613-5mgProduct description:BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <:2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with
-
B126876-100mgBMS-345541 has been used: as an IκB kinase (IKK) complex inhibitor to study its effects on the interferon-γ (IFN-γ) production by natural killer (NK) cells as an IKK inhibitor to study its effects on the expression of eotaxin and monocyte
-
B126876-10mgBMS-345541 has been used: as an IκB kinase (IKK) complex inhibitor to study its effects on the interferon-γ (IFN-γ) production by natural killer (NK) cells as an IKK inhibitor to study its effects on the expression of eotaxin and monocyte
-
B126876-25mgBMS-345541 has been used: as an IκB kinase (IKK) complex inhibitor to study its effects on the interferon-γ (IFN-γ) production by natural killer (NK) cells as an IKK inhibitor to study its effects on the expression of eotaxin and monocyte